To improve the access of innovative drugs for oncology and rare diseases, Takeda China and Magnesium Trust Health reached a strategic partnership

Reduce the financial burden with innovative payment models that allow more patients to benefit from innovative drugs and standardized treatments. Takeda China has reached a strategic partnership with Magnesium Health, which will explore high-quality advanced medical services and diversified and innovative payment models through the integration and innovation of medical health and insurance services.
In recent years, in order to further improve the access of innovative drugs and reduce the financial burden on patients, the state has issued a number of policies to help build a more comprehensive multi-level medical security system, encouraging the use of commercial health insurance and other innovative payment methods to help patients solve the problem of medical payment, so that more patients can see the disease, affordable medicine.
With the continuous development and improvement of China's health care system, commercial insurance will play an increasingly important role in the future," said Mr. Shan Guohong, president of Takeda China. Takeda China looks forward to working with Magnesium Health to explore innovative payment models to help the government build a more comprehensive multi-party health care system to provide medical services and drug protection to more Chinese patients.
Focus on new special drugs, chronic drugs, rare drugs, equipment medical payment services magnesium letter health, at the signing ceremony Zhang Xiaodong President pointed out that magnesium letter will give full play to the experience of the field of innovative payment advantages, for Takeda's product development more access to innovative payment programs, and jointly help build a multi-level security system in the field of drug payment, so that high-quality medical resources benefit the people of the country.